161. The Joseph P. Kennedy, Jr., Laboratories for Molecular Medicine

Format:

Text

162. Demographic and Epidemiological Studies

Format:

Text

163. Possible Comments on BW

Format:

Text

164. CBW Considerations in CCD

Format:

Text

165. Working Paper on Remarks by Dr. Joshua Lederberg at Informal Meeting of CCD, 5 August 1970

Format:

Text

166. Towards Preventing a Biological Weapons Technology Race

Format:

Text

167. Discussions in Moscow Regarding Sverdlovsk Anthrax Outbreak

Format:

Text

168. High Points of an Interim Report: DSB/DPB Task Force on CBW

Format:

Text

169. Towards Preventing a Biological Weapons Technology Race (European version)

Format:

Text

170. General considerations of biological warfare, arms control, and proliferation

Format:

Text

171. Anthrax Epidemic in Sverdlovsk 1979 and Soviet Compliance with the BW Disarmament Convention, CISAC-Moscow October 8, 1986

Format:

Text

172. Status of Toxins Under the BWC

Format:

Text

173. Methodology to Determine Biomaterial Stockpile Limits on the Basis of Danger Classification Groups

Format:

Text

174. Summary of Conclusions and Decisions: CISAC Working Group on Biological Weapons Control Planning Meeting October 5, 1993

Format:

Text

175. Visit to Russia on Collaborative Research on Dangerous Pathogens, November 21-30, 1996

Format:

Text

176. Controlling Dangerous Pathogens: A Blueprint for U.S.-Russian Cooperation

Format:

Text

177. Controlling Dangerous Pathogens: A Blueprint for U.S.-Russian Cooperation (Introduction & Table of Contents)

Format:

Text

178. Controlling Dangerous Pathogens: A Blueprint for U.S.-Russian Cooperation (pages 51-78)

Format:

Text

179. Controlling Dangerous Pathogens: A Blueprint for U.S.-Russian Cooperation (pages 26-50)

Format:

Text

180. Controlling Dangerous Pathogens: A Blueprint for U.S.-Russian Cooperation (pages 1-25)

Format:

Text